mineral oil

Botanicalexperimental

Clinical trial activity

9 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
1

Earliest trial started Feb 1, 2006 (NCT00569569)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • retaine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06898853N/AMay 1, 2025University of Melbourne, University of New South Wales
NCT05660382Phase 3May 31, 2023Hill Dermaceuticals, Inc.
NCT05555524N/AOct 2, 2022Alexandria University
NCT06135844Early Phase 1 (Phase 1)Apr 8, 2022Idaho State University
NCT04493333Phase 2Dec 31, 2020AMAG Pharmaceuticals, Inc., University of Arkansas
NCT04874857N/ANov 25, 2020Erciyes University
NCT02139033Phase 4May 1, 2014Ocusoft, Inc., ORA, Inc.
NCT02084472N/AFeb 28, 2013Red Cross War Memorial Childrens Hospital, University of Cape Town
NCT00569569Phase 2/Phase 3 (Phase 3)Feb 1, 2006Rudolf Foundation Clinic
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Alexandria UniversityAcademic/Hospital1112022
AMAG Pharmaceuticals, Inc.For profit1012020
Erciyes UniversityAcademic/Hospital1112020
Hill Dermaceuticals, Inc.For profit1112023
Idaho State UniversityAcademic/Hospital1112022
Ocusoft, Inc.For profit1112014
ORA, Inc.For profit1012014
Red Cross War Memorial Childrens HospitalAcademic/Hospital1112013
Rudolf Foundation ClinicAcademic/Hospital1112006
University of ArkansasAcademic/Hospital1112020
University of Cape TownAcademic/Hospital1012013
University of MelbourneAcademic/Hospital1012025
University of New South WalesAcademic/Hospital1112025
13 organizations
Page 1 / 1